These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 7696887

  • 1. Effect of nandrolone decanoate and 1-alpha-hydroxy-calciferol on patients with vertebral osteoporotic collapse. A double-blind clinical trial.
    Lyritis GP, Androulakis C, Magiasis B, Charalambaki Z, Tsakalakos N.
    Bone Miner; 1994 Dec; 27(3):209-17. PubMed ID: 7696887
    [Abstract] [Full Text] [Related]

  • 2. Effects of nandrolone decanoate on bone mass in established osteoporosis.
    Passeri M, Pedrazzoni M, Pioli G, Butturini L, Ruys AH, Cortenraad MG.
    Maturitas; 1993 Nov; 17(3):211-9. PubMed ID: 8133796
    [Abstract] [Full Text] [Related]

  • 3. Nandrolone decanoate and intranasal calcitonin as therapy in established osteoporosis.
    Flicker L, Hopper JL, Larkins RG, Lichtenstein M, Buirski G, Wark JD.
    Osteoporos Int; 1997 Nov; 7(1):29-35. PubMed ID: 9102059
    [Abstract] [Full Text] [Related]

  • 4. Bone mineral content, cortical thickness and fracture rate in osteoporotic women after withdrawal of treatment with nandrolone decanoate, 1-alpha hydroxyvitamin D3, or intermittent calcium infusions.
    Geusens P, Dequeker J, Verstraeten A, Nijs J, Van Holsbeeck M.
    Maturitas; 1986 Dec; 8(4):281-9. PubMed ID: 3574141
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Double-blind placebo--controlled trial of nandrolone decanoate in postmenopausal osteoporosis.
    Chhaparwal M, Saraf ML.
    Indian J Med Sci; 1998 Jun; 52(6):236-8. PubMed ID: 9849033
    [No Abstract] [Full Text] [Related]

  • 9. Vitamin D metabolism in osteoporotic women during treatment with estrogen, an anabolic steroid, or calcitonin.
    Hartwell D, Hassager C, Overgaard K, Riis BJ, Pødenphant JR, Christiansen C.
    Acta Endocrinol (Copenh); 1990 Jun; 122(6):715-21. PubMed ID: 2375235
    [Abstract] [Full Text] [Related]

  • 10. Effects of 1 alpha-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis.
    Orimo H, Shiraki M, Hayashi Y, Hoshino T, Onaya T, Miyazaki S, Kurosawa H, Nakamura T, Ogawa N.
    Calcif Tissue Int; 1994 May; 54(5):370-6. PubMed ID: 8062152
    [Abstract] [Full Text] [Related]

  • 11. The effect of nandrolone decanoate on bone mineral density, muscle mass, and hemoglobin levels in elderly women with osteoporosis: a double-blind, randomized, placebo-controlled clinical trial.
    Frisoli A, Chaves PH, Pinheiro MM, Szejnfeld VL.
    J Gerontol A Biol Sci Med Sci; 2005 May; 60(5):648-53. PubMed ID: 15972619
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Effects on the bones of nandrolone decanoate therapy in postmenopausal osteoporosis].
    Gennari C, Agnusdei D, Gonnelli S.
    Minerva Endocrinol; 1989 May; 14(1):69-74. PubMed ID: 2659955
    [Abstract] [Full Text] [Related]

  • 14. The androgenic anabolic steroid nandrolone decanoate prevents osteopenia and inhibits bone turnover in ovariectomized cynomolgus monkeys.
    Jerome CP, Power RA, Obasanjo IO, Register TC, Guidry M, Carlson CS, Weaver DS.
    Bone; 1997 Apr; 20(4):355-64. PubMed ID: 9108356
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of combined treatment with etidronate, nandrolone-decanoate and calcium on bone mineral density in postmenopausal women.
    Bolanca S, Korsić M, Dekanić D, Cvijetić S.
    Acta Med Croatica; 1998 Apr; 52(3):159-63. PubMed ID: 9818438
    [Abstract] [Full Text] [Related]

  • 17. Mechanical properties, bone mineral content, and bone composition (collagen, osteocalcin, IGF-I) of the rat femur: influence of ovariectomy and nandrolone decanoate (anabolic steroid) treatment.
    Aerssens J, Van Audekercke R, Geusens P, Schot LP, Osman AA, Dequeker J.
    Calcif Tissue Int; 1993 Oct; 53(4):269-77. PubMed ID: 8275356
    [Abstract] [Full Text] [Related]

  • 18. Changes in soft tissue body composition and plasma lipid metabolism during nandrolone decanoate therapy in postmenopausal osteoporotic women.
    Hassager C, Pødenphant J, Riis BJ, Johansen JS, Jensen J, Christiansen C.
    Metabolism; 1989 Mar; 38(3):238-42. PubMed ID: 2645503
    [Abstract] [Full Text] [Related]

  • 19. The carboxy-terminal propeptide of type I procollagen in serum as a marker of bone formation: the effect of nandrolone decanoate and female sex hormones.
    Hassager C, Jensen LT, Johansen JS, Riis BJ, Melkko J, Pødenphant J, Risteli L, Christiansen C, Risteli J.
    Metabolism; 1991 Feb; 40(2):205-8. PubMed ID: 1988778
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.